drcom announces Ian Willoughby as new Business Development Director

Singapore, 1st October 2024 – drcom, an independent global life sciences medico-marketing agency, is pleased to announce the appointment of Mr. Ian Willoughby as their new Business Development Director for the APAC region.

Located in Singapore, Ian will work closely with the drcom teams across APAC and ANZ, ensuring that their vision to transform health communications between healthcare professionals (HCPs), patients, and consumers is achieved through strong client partnerships.

Ian brings a wealth of experience from his extensive career in major pharmaceutical companies and healthcare communications and medical education businesses in the UK, Australia, and Singapore. His expertise spans a wide range of specialist, general practice, and consumer health brands.

Commenting on his new role, Ian said, “It’s a very exciting time to join drcom. Their commitment to driving positive impact in health and care across Asia and Europe is inspiring. Their continuous investment in innovative ways to provide new opportunities for education and communication for prescribers and patients will lead to impactful and purposeful outcomes. I look forward to leading these initiatives across the region.”

About drcom
drcom is a global life sciences medico-marketing agency with omnichannel & storytelling expertise. Founded more than 2 decades ago, drcom is a pioneer of digital communication and omnichannel management in healthcare. Its team leverage customized content, data-driven personalization, artificial intelligence & interactive innovation to deliver an immersive omnichannel experience for Healthcare professionals and for patients. drcom supports over 30 life sciences companies globally (Sanofi, Boehringer-Ingelheim, Takeda, Nestlé, Santen & Abbott etc) with presence in France, Singapore, China, Vietnam, Philippines and Australia.

For media enquiries or further information, please contact Mr. Ian Willoughby at ian.willoughby@drcomgroup.com or +65 8786 7543

for further contact.